Thema
610
74
Study Type: Interventional
66
Recruitment Status: Not yet recruiting
24
Recruitment Status: Authorised-recruitment may be ongoing or finished
22
Recruitment Status: Completed
14
Recruitment Status: Recruiting
10
Journal Article
6
Phase: Phase 3
6
Phase: Phase 4
6
aging
5
Phase: Phase 2
4
Study Type: Observational
4
Study Type: Observational non invasive
4
Psychology of ageing
3
medical science;replacing body parts;cognitive enhancers;lifestyle drugs;prosthetics;hormone supplements;enhancement technologies;realistic;evolution;science and math;scientists;humanity;page turner;engaging;medical;historical;ageing medicine;ethnographic insights;aesthetic surgery;technologies;anthropology;aging;cultural;social;social science;sexual enhancers;surgery;technological capacity;reject enhancement;plastic cosmetic;appearance
3
AGED
2
AGED/diseases
2
Age groups: children
2
COVID-19
2
Medical Condition: -patients with FHBL and liver steatosis-healthy controls matched for age, BMI, waist circumference and physical activity
2
Medical Condition: Age equal or above 65 yearsClinical underlyng conditions indicating influenza vaccination Influenza, vaccination;Influenza, vaccination
2
Medical Condition: Age related muscle loss i.e. sarcopenia; Age related muscle loss i.e. sarcopenia;Musculoskeletal - Other muscular and skeletal disorders
2
Medical Condition: Age-related macular degeneration Eye Diseases Other retinal disorders
2
Medical Condition: Alzheimer, dementia, ageing, oldest old
2
Medical Condition: AsthmaAlthough we are looking at recruit from a population of infants that have been diagnosed with bronchiolitis, this is because we know that this population has a higher risk of developing wheezing and atopy in childhood, so we believe our likely incidence of asthma by the age of three will be higher in this population than in the general population. ; AsthmaAlthough we are looking at recruit from a population of infants that have been diagnosed with bronchiolitis, this is because we know that this population has a higher risk of developing wheezing and atopy in childhood, so we believe our likely incidence of asthma by the age of three will be higher in this population than in the general population. ;Respiratory - Asthma
2
Medical Condition: B-cell lymphoma or B-ALL in children up to 18 years of age
2
Medical Condition: Children aged from 2 to 8 years old requiring tonsillectomy MedDRA version: 8.1Level: LLTClassification code 10044008Term: Tonsillitis
2
Medical Condition: Dégénérescence Maculaire Liée à l’Age (DMLA) MedDRA version: 9.1Level: LLTClassification code 10064930Term: Age-related macular degeneration
2
Medical Condition: Exudative age-related macular degeneration
2
Medical Condition: Health Condition 1: M810- Age-related osteoporosis without current pathological fracture
2
Medical Condition: Health Condition 1: null- Patient having sign and symptoms of Shwitra(Vitiligo),Curable symptoms(sadhya laxana) of disease, age 16-60 years, Woods lamp test positive are to be selected.
2
Medical Condition: Health Condition 1: null- a total of 80 patients aged 20 to 60 years with ASA II or III physical status with BMI of 30 or more scheduled for laparoscopic urological procedures under general anesthesia.
2
Medical Condition: Healthy older subjects (age 65 years or older)
2
Medical Condition: Het valrisico wordt gemeten aan de hand van de FRAA (Fall Risk Assessment Algorithm) en fysieke performance testen. Inclusie criteria voor deze studie zijn zelfstandig thuis wonende ouderen van 65 jaar of ouder en een score van &#8805; 3 op de Funtional Ambulation Categories (FAC). Dit betekent dat mensen geen hulp (fysiek contact) nodig hebben bij het bewaren van balans of coördinatie en zelfstandig kunnen lopen. <br /><br />The aim of this study is to investigate whether the used parameters of the fall risk application algorithm (FRAA) of the GoLivePhone® software are valid. Inclusion criteria for the study are people living without help, age 65years or older and a score of &#8805; 3 on the Funtional Ambulation Categories (FAC).
2
Medical Condition: Loss of muscle mass in healthy aging (sarcopenia)
2
Medical Condition: Major Diseases in Aging
2
Medical Condition: MedDRA version: 16.1Level: PTClassification code 10064930Term: Age-related macular degenerationSystem Organ Class: 10015919 - Eye disorders;Therapeutic area: Diseases [C] - Eye Diseases [C11]
2
Medical Condition: Men and women over 40 years of age, with a diagnosis of COVID-19 infection and at least one high risk criterion.;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Neovascular (exudative) age-related macular degeneration MedDRA version: 9.1Level: LLTClassification code 10015902Term: Exudative senile macular degeneration of retina
2
Medical Condition: Neovascular Age-related Macular Degeneration (nAMD)
2
Medical Condition: Neovascular Age-related macular degeneration MedDRA version: 20.1Level: PTClassification code 10064930Term: Age-related macular degenerationSystem Organ Class: 10015919 - Eye disorders;Therapeutic area: Diseases [C] - Eye Diseases [C11]
2
Medical Condition: None. The target group for this study are people in the general population aged 18 years and older who suffer from reduced well-being and mild or moderate psychological complaints, partly as a result of the corona crisis.
2
Medical Condition: Older adults 73-79 years of age, birth cohorts year 1941-1947, still participating in round 6 of the Doetinchem Cohort Study.;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Patient âgé de 75 ans et plus porteurs d'un cancer de l'oesophage non opérable et avec une maladie localisée;Therapeutic area: Diseases [C] - Cancer [C04]
2
Medical Condition: Patients experiencing severe irreversible vision loss as a result of age-related macular degeneration (ARMD)
2
Medical Condition: Patients with liverfailure above 18 years of age, who is submitted to the waiting list for a liver transplantation
2
Medical Condition: PolypharmacyMedication Therapy ManagementDecision Support Systems ManagementAgedMedication review
2
Medical Condition: Severe early - onset Intrauterine Growth Restriction (IUGR), (also referred to as Fetal growth restriction) diagnosed between 22+0 and 29+6 gestational age. IUGR is defined as an estimated fetal weight <10th centile OR Abdominal circumference <10th centile AND absent or reversed end diastolic flow in the umbilical artery. MedDRA version: 19.0Level: LLTClassification code 10070532Term: Fetal growth restrictionSystem Organ Class: 100000004868;Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
2
Medical Condition: Severe hemophilia A (FVIII:C <1%) in male subjects <6 years of age.Hemofilia A severa (FVIII:C<1%) en sujetos pediátricos menores de seis años de edad. MedDRA version: 9.1Level: LLTClassification code 10018937Term: Haemophilia A
2
Medical Condition: Skin aging
2
mehr ...